Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2003
12/11/2003US20030229015 Atherosclerosis; anticholesterol agents
12/11/2003US20030229014 Agents and methods for promoting bone growth
12/11/2003US20030229013 Drug delivery
12/11/2003US20030229012 Administering transferrin for blood disorders
12/11/2003US20030229010 Antidiabetic agents; water in oil microemulsion; immobilization
12/11/2003US20030229008 Regenerating organs; anticancer agents; autoimmune disease; stabilization cells
12/11/2003US20030229007 Form of human renin and its use as a target in treatments for cardiac ischemia and arrhythmia
12/11/2003US20030229006 Amphiphilic oligomers
12/11/2003US20030229004 Modulation of tumor cells using BER inhibitors in combination with a sensitizing agent and DSBR inhibitors
12/11/2003US20030229003 Use of transcription factors for treating inflammation and other diseases
12/11/2003US20030229000 Therapy, prevention of microorganism infection; contacting surfaces; signal passageway
12/11/2003US20030228691 Processes for inhibiting gene expression using polynucleotides
12/11/2003US20030228690 Antisense modulation of IL-1 receptor-associated kinase-1 expression
12/11/2003US20030228689 Antisense modulation of G protein-coupled receptor kinase 6 expression
12/11/2003US20030228688 Antisense modulation of isoprenylcysteine carboxyl methyltransferase expression
12/11/2003US20030228677 AMID protein, nucleic acid molecules, and uses thereof
12/11/2003US20030228674 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
12/11/2003US20030228667 Modulator of nuclear factor alpha beta for treating defects in immune responses, stress responses, inflammation or apoptosis
12/11/2003US20030228665 Production of human parathyroid hormone from microorganisms
12/11/2003US20030228662 Comprises nucleotide sequences coding tetrodoxin resistant transport protein for diagnosing, prevention and treatment of pain, muscular and cardiac disorders
12/11/2003US20030228653 Novel orphan cytokine receptor polypeptides
12/11/2003US20030228652 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
12/11/2003US20030228625 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
12/11/2003US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof
12/11/2003US20030228595 Peptides and proteins that effect protein phosphorylation; useful in the development of human therapeutics and diagnostic formulations
12/11/2003US20030228592 Human facilitative glucose transport protein GLUT8
12/11/2003US20030228587 IWU-1 is a protein of 115 amino acids with a calculated molecular mass of 12.9 kDa, cloned from a cDNA molecule of human bone marrow having 347 nucleotides
12/11/2003US20030228584 Novel nucleic acids and polypeptides
12/11/2003US20030228576 Nucleotide sequence coding for a cleaving enzyme; can use in conjuction with substrate to produce toxins which impair abnormal cell growth; antitumor agents
12/11/2003US20030228568 Inducible phosphofructokinase and the warburg effect
12/11/2003US20030228371 Anti-infarction molecules
12/11/2003US20030228365 Pharmaceutical formulation
12/11/2003US20030228353 Wound heraling agents; polypeptide
12/11/2003US20030228345 Genetic engineered protein; bone disorders
12/11/2003US20030228321 Preventives for reinfection after liver transplantation
12/11/2003US20030228318 PSCA: prostate stem cell antigen and uses thereof
12/11/2003US20030228317 Antitumor agents; anticancer agents
12/11/2003US20030228312 TNF receptor-specific antibodies
12/11/2003US20030228310 Autoimmune diseases; administering interferon antibody
12/11/2003US20030228307 Binding to platelet derived growth factor
12/11/2003US20030228301 Genetic engineering; polypeptide binding to antibody
12/11/2003US20030228299 Using superoxide dismutase
12/11/2003US20030228298 Antiproliferative agents
12/11/2003US20030228297 Lactobacilli expressing biologically active polypeptides and uses thereof
12/11/2003US20030228295 Use of human neural stem cells secreting GDNF for treatment of parkinson's and other neurodegenerative diseases
12/11/2003US20030228294 Inhibition of tumor growth via peroxiredoxin 3
12/11/2003US20030228292 Methods of inducing or enhancing connective tissue repair
12/11/2003US20030228291 Polynucleotide that encodes a polypeptide; binding specificity; useful in bone marrow transplantation and gene therapy
12/11/2003US20030228289 Universal chimera bank
12/11/2003US20030228285 Bipartite T-cell factor (Tcf)-responsive promoter
12/11/2003US20030228283 Preventing secondary lymphedema with VEGF-D DNA
12/11/2003US20030228281 Use of mutant herpes viruses and anticancer agents in the treatment of cancer
12/11/2003US20030228277 Reduce concentration of reactive oxygen metabolites
12/11/2003US20030228276 Administering tumor necrosis factor; signal transduction passageways; transgenic rodent model
12/11/2003US20030228275 Immobilization of drugs
12/11/2003US20030228258 Suicide tetramers and uses thereof
12/11/2003CA2736974A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2736972A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2736926A1 Tumour associated peptides that bind to mhc molecules
12/11/2003CA2736921A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2494451A1 Treatment of cell proliferative disorders with chlorotoxin
12/11/2003CA2491420A1 Rb1 gene induced protein (rb1cc1) and gene
12/11/2003CA2488547A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/11/2003CA2488539A1 Novel proteins and nucleic acids encoding same
12/11/2003CA2488238A1 Method for reducing obstructive hydrocephalus
12/11/2003CA2488048A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
12/11/2003CA2488012A1 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis
12/11/2003CA2487939A1 Semaphorin-like proteins and methods of using same
12/11/2003CA2487926A1 Suicide tetramers comprising mhc class i and uses thereof
12/11/2003CA2487915A1 Allergen from mugwort pollen
12/11/2003CA2487897A1 Helper virus-free herpesvirus amplicon particles and uses thereof
12/11/2003CA2487895A1 Defensins: use as antiviral agents
12/11/2003CA2487867A1 Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion
12/11/2003CA2487815A1 Targeted therapeutic proteins
12/11/2003CA2487730A1 Sgk and nedd used as diagnostic and therapeutic targets
12/11/2003CA2487678A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone
12/11/2003CA2487597A1 Bacterial transforming agent
12/11/2003CA2487585A1 Formulations for amylin agonist peptides
12/11/2003CA2487427A1 Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules
12/11/2003CA2487425A1 Combination chemotherapy with chlorotoxin
12/11/2003CA2487410A1 Intramyocardial injection of autologous bone marrow
12/11/2003CA2487305A1 Topical drug delivery using phosphatidylcholine
12/11/2003CA2487299A1 Treatment of hepatitis c in the asian population with subcutaneous interferon-beta
12/11/2003CA2487291A1 Human prolactin antagonist-angiogenesis inhibitor fusion proteins
12/11/2003CA2487024A1 Control sequences of the human corin gene
12/11/2003CA2486911A1 Method of screening groups of radioactive molecules and applications thereof
12/11/2003CA2485194A1 Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
12/11/2003CA2484626A1 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
12/11/2003CA2483145A1 Transgenic plants with controlled distribution of a trait to progeny
12/11/2003CA2390285A1 Non-mitogenic fgf-2 protects against ischemia and/or reperfusion injury
12/10/2003EP1369491A1 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
12/10/2003EP1369487A2 Recombinant vectors derived from adenovirus for use in gene therapy
12/10/2003EP1369483A1 Allergen from mugwort pollen
12/10/2003EP1369428A1 Muc-1 derivatives and their use in treating cancer-associated MUC-1 Mucin-induced immunosuppression
12/10/2003EP1369426A1 Peptides, derivatives thereof, process for producing the same, strain producing the same, and antiviral agent comprising the same as active ingredient
12/10/2003EP1369425A1 Thiopeptide compounds
12/10/2003EP1369128A1 Inhibitors of glycoprotein VI and their therapeutic use
12/10/2003EP1369125A1 Treatment of partial growth hormone insensitivity syndrome
12/10/2003EP1369124A1 High density lipoprotein against organ dysfunction following haemorrhagic shock
12/10/2003EP1369120A1 Treatment of flavivirus infection
1 ... 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 ... 3163